Literature DB >> 15977311

Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.

A Atzei1, K Gajewska, I C Huggon, L Allan, K H Nicolaides.   

Abstract

OBJECTIVE: To define the prevalence of major cardiac defects according to nuchal translucency (NT) thickness at the 11 to 13 + 6-week scan in fetuses with normal karyotype.
METHODS: Specialist fetal echocardiography was carried in 6921 fetuses with normal or presumed normal karyotype at a median gestation of 20 (range 12-35) weeks. The indications for fetal echocardiography were increased NT thickness (n = 3444), detailed second-trimester scan either for assessment of risk of chromosomal abnormalities (n = 2980) or previous or family history of fetal defects (n = 497). The cardiac defects were grouped into six functional categories: septal defect, left inflow obstruction, right inflow obstruction, left outflow obstruction, right outflow obstruction and other.
RESULTS: Major cardiac defects were identified in 132 (19.1 per 1000) fetuses and the prevalence increased with fetal NT thickness from 4.9 per 1000 in those with NT below the median, to 8.7 for NT between the median and less than the 95th centile, 18.2 for NT between the 95th and 99th centiles, and exponentially thereafter to 35.2, 64.4 and 126.7 for respective NTs of 3.5-4.4 mm, 4.5-5.4 mm and > or = 5.5 mm. There was no obvious difference in the distribution of NT in the different types of cardiac defects.
CONCLUSIONS: The prevalence of major cardiac defects increases exponentially with fetal NT thickness and in fetuses with NT of 3.5 mm or more it is higher than in pregnancies with a family history of cardiac defects. Copyright 2005 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15977311     DOI: 10.1002/uog.1936

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  9 in total

Review 1.  Three- and 4-dimensional ultrasound in obstetric practice: does it help?

Authors:  Luís F Gonçalves; Wesley Lee; Jimmy Espinoza; Roberto Romero
Journal:  J Ultrasound Med       Date:  2005-12       Impact factor: 2.153

2.  Increased nuchal traslucency in normal karyotype fetuses.

Authors:  Roberta De Domenico; Marianna Faraci; Entela Hyseni; Fosca A F Di Prima; Oriana Valenti; Santo Monte; Elsa Giorgio; Eliana Renda
Journal:  J Prenat Med       Date:  2011-04

3.  The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.

Authors:  Emily Suskin; Laura Hercher; Kathleen Erskine Aaron; Komal Bajaj
Journal:  J Genet Couns       Date:  2016-02-15       Impact factor: 2.537

Review 4.  Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy.

Authors:  Laura Goetzl
Journal:  Clin Lab Med       Date:  2010-09       Impact factor: 1.935

5.  Impact of fetal echocardiography.

Authors:  John M Simpson
Journal:  Ann Pediatr Cardiol       Date:  2009-01

6.  Increased nuchal translucency and pregnancy outcomes: experience of Başkent University Ankara Hospital.

Authors:  Nihal Şahin Uysal; Çağrı Gülümser; Zerrin Yılmaz Çelik; Filiz Bilgin Yanık
Journal:  Turk J Obstet Gynecol       Date:  2019-07-03

7.  Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening.

Authors:  Liubing Lan; Heming Wu; Lingna She; Bosen Zhang; Yanhong He; Dandan Luo; Huaxian Wang; Zhiyuan Zheng
Journal:  J Clin Lab Anal       Date:  2020-04-27       Impact factor: 2.352

Review 8.  Fetal nuchal edema and developmental anomalies caused by gene mutations in mice.

Authors:  Akira Sugiyama; Masanori Hirashima
Journal:  Front Cell Dev Biol       Date:  2022-08-30

9.  First trimester screening using ultrasound and serum markers in Panamanians: Factors associated with adverse pregnancy outcomes.

Authors:  Tania T Herrera; Scarlett Sinisterra; Alcibiades Solis; Gabrielle B Britton
Journal:  J Res Med Sci       Date:  2014-05       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.